{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:36:27Z","timestamp":1782804987607,"version":"3.54.5"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>Central giant cell granuloma of the jaw (CGCJ) can be locally aggressive and result in facial and dental deformity. A child with CGCJ was treated surgically and with denosumab with a response but life-threatening toxicity. Imatinib, a tyrosine kinase inhibitor, was prescribed based on clinical similarities between CGCJ and cherubism, for which Imatinib has been effective. Within 2 months, a computed tomographic scan showed significant ossification, which increased over the following 8 months. This case suggests that tyrosine kinase inhibitors may be an effective option, and one with limited toxicity, for CGCJ.<\/jats:p>","DOI":"10.1097\/mph.0000000000002608","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T17:26:46Z","timestamp":1674840406000},"page":"278-280","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Response of Central Giant Cell Granuloma of the Jaw to Imatinib"],"prefix":"10.1097","volume":"45","author":[{"given":"Brian","family":"Tallent","sequence":"first","affiliation":[{"name":"Southeast Oral & Maxillofacial Associates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Padilla","sequence":"additional","affiliation":[{"name":"Division of Oral and Maxillofacial Pathology Laboratory, The University of North Carolina Adams School of Dentistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"McKay","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Atrium Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Katherine M.","family":"Foreman","sequence":"additional","affiliation":[{"name":"Department of Genetics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of North Carolina School of Medicine, Charlotte, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7658-8096","authenticated-orcid":false,"given":"Julie","family":"Blatt","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology Oncology"},{"name":"The Lineberger Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/path.5365","article-title":"Making sense of giant cell lesions of the jaws (GCLJ)","volume":"250","author":"Gomes","year":"2020","journal-title":"J Pathol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.tripleo.2007.04.003","article-title":"Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options","volume":"104","author":"de Lange","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"e28778","DOI":"10.1002\/pbc.28778","article-title":"Treatment of central giant cell granuloma in children with denosumab","volume":"68","author":"Choe","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"101148","DOI":"10.1016\/j.bonr.2021.101148","article-title":"Hypercalcemia following discontinuation of denosumab therapy: a systematic review","volume":"15","author":"Horiuchi","year":"2021","journal-title":"Bone Rep"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1097\/MPH.0000000000000380","article-title":"Zoledronic Acid for the Treatment of Children With Refractory Central Giant Cell Granuloma","volume":"37","author":"Chien","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1278.e1","DOI":"10.1016\/j.joms.2019.02.021","article-title":"A paradigm shift in the management of cherubism? A preliminary report using imatinib","volume":"77","author":"Ricalde","year":"2019","journal-title":"J Oral Maxillofac Surg"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bjoms.2007.04.014","article-title":"Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumors of the jaw","volume":"46","author":"Idowu","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1182\/blood-2005-09-3568","article-title":"Imatinib as a potential antiresorptive therapy for bone disease","volume":"107","author":"Dewar","year":"2006","journal-title":"Blood"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bjoms.2008.05.013","article-title":"Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report","volume":"47","author":"De Lange","year":"2009","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-term outcomes of imatinib treatment for chronic myeloid leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N Engl J Med"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10815-021-02181-6","article-title":"Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review","volume":"38","author":"Rambhatla","year":"2021","journal-title":"J Assist Reprod Genet"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:06:07Z","timestamp":1754337967000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002608","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,19]]},"assertion":[{"value":"2022-09-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}